The Wilmer Eye Institute at Johns Hopkins University Receives Helmsley Charitable Trust Research Grant for Integrin Peptide Therapy – a New Drug Class to Treat Vascular Eye Diseases

BALTIMORE & SAN JUAN CAPISTRANO, Calif.--(BUSINESS WIRE)--Allegro Ophthalmics, LLC announced that its research collaboration with The Wilmer Eye Institute at Johns Hopkins has received a grant in excess of $600,000 from the Leona M. and Harry B. Helmsley Charitable Trust to further the development of Allegro’s new Integrin Peptide Therapy™. The research advances a new drug class for the treatment of eye diseases such as diabetic retinopathy, diabetic macular edema and wet age-related macular degeneration.